Nu Skin Enterprises, Inc. Class A (NUS)

In the past six months, Nu Skin's stock experienced several notable events. The company announced its second-quarter 2025 results on August 7, 2025, reporting revenue at the high end of its guidance range and EPS exceeding guidance. On November 6, 2025, Nu Skin announced its third-quarter 2025 earnings, with EPS of $0.34, surpassing the consensus estimate of $0.30, although quarterly revenue of $364.21 million was below analysts' expectations. Following this announcement, Nu Skin's stock saw a slight dip of 2.16% in aftermarket trading. The company also declared quarterly cash dividends of $0.06 per share, with ex-dividend dates on August 29, 2025, and November 28, 2025. Nu Skin is expected to release its fourth-quarter and full-year 2025 results after the market closes on Thursday, February 12, 2026. In January 2025, Nu Skin's Rhyz Inc. subsidiary completed a strategic transaction, selling its Mavely affiliate marketing technology platform for approximately $250 million in cash and a minority equity stake.

The provided information does not explicitly detail the demand seasonality for Nu Skin Enterprises, Inc.'s products and services. However, demand can sometimes be influenced by seasonal consumer spending patterns, holiday promotions, and new product launches. The company's focus on new product innovations and market expansions suggests ongoing efforts to stimulate demand.

Nu Skin Enterprises, Inc. is a global direct-selling company specializing in beauty, personal care products, and nutritional supplements. It operates in the health and wellness and beauty industries, driven by consumer focus on well-being and self-care. The company's major product categories include beauty and wellness products distributed under the Nu Skin, Pharmanex, and ageLOC brands. Key product offerings include skincare devices, nutritional supplements, and weight management systems. Nu Skin is recognized as the world's largest beauty and wellness device systems brand.

Nu Skin Enterprises distributes its products in over 50 markets across the Americas, Europe, Africa, and Asia. The company's operations are segmented into geographic regions, including Mainland China, South Korea, Southeast Asia/Pacific, Americas, Japan, Hong Kong/Taiwan, and Europe, Middle East & Africa.

Nu Skin has maintained a strong reputation, being ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. for the second consecutive year as of September 30, 2025. However, some reports from March 2024 indicated challenges related to falling sales and margins, and concerns about the multi-level marketing model. Customer and dermatologist reviews regarding Nu Skin products have been mixed.

Nu Skin Enterprises, Inc. has a diverse ownership structure, with institutional investors holding a significant majority of the company's stock. Approximately 36.61% of the company's stock is owned by Institutional Investors, 3.31% by Insiders, and 60.08% by Public Companies and Individual Investors. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., Charles Schwab Investment Management Inc., Renaissance Technologies Llc, Prescott Group Capital Management, L.l.c., American Century Companies Inc., Morgan Stanley, D. E. Shaw & Co., Inc., and iShares Russell 2000 ETF. The company's co-founders, Blake Roney, Sandie Tillotson, and Steve Lund, also maintain notable individual stakes.